[Estimation of the projections of incidence rates, prevalence and mortality due to prostate cancer in Aragon (Spain)].

Autor:	Bernal M; Departamento de Medicina Preventiva, Universidad de Zaragoza, España. mibernal@unizar.es, Romero FJ, Souza DL, Gómez-Bernal FJ, Gómez-Bernal GJ
Jazyk:	Spanish; Castilian
Zdroj:	Actas urologicas espanolas [Actas Urol Esp] 2011 Sep; Vol. 35 (8), pp. 470-4. Date of Electronic Publication: 2011 May 28.
DOI:	10.1016/j.acuro.2011.03.010
Abstrakt:	Objective: The purpose of this study was to project prostate cancer prevalence, incidence rates and mortality over a 15-year period going from 2008 to 2022 for the Aragon region of Spain. Methods: The projections were calculated using the MIAMOD PROGRAM. All-cause mortality due to prostate cancer for the baseline period of 1998 to 2007 was obtained from the Spanish National Institute of Statistics. Results: The prostate cancer incidence rates for the period 2008 to 2022 per 100,000 persons are projected to decrease from 47.57 to 26.68/100,000 (adjusted rates 24.9 to 12.93). Mortality will decrease from 21.89 to 11.73 (adjusted rates 10.89 to 5.83) and prevalence from 277.07 cases/ 100,000 per year to 125.09 (adjusted rates 165.54 to 63.41). Conclusions: These projections indicate that the prostate cancer incidence and its mortality rate will decrease in Aragon (Spain). (Copyright © 2011 AEU. Published by Elsevier Espana. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu